AjayNirulaMD

Senior Vice President, Immunology, Eli Lilly

Dr. Nirula is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1997 - 2000
David Geffen School of Medicine at UCLAClass of 1997

PubMed

89 citations
Clinical meaningfulness of complete skin clearance in psoriasis
Bruce Strober, Kim A. Papp, Mark Lebwohl, Kristian Reich, Carle Paul
Journal of the American Academy of Dermatology. 2016-07-01
840 citations
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
Peter Chen, Ajay Nirula, Barry Heller, Robert L. Gottlieb, Joseph Boscia
The New England Journal of Medicine. 2021-01-21
32 citations
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
Kara W Chew, Carlee Moser, Eric S Daar, David A Wohl, Jonathan Z Li
Nature Communications. 2022-08-22

Journal Articles

Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID ‐19 patients
Justin Stebbing Venkatesh Krishnan Stephanie de Bono Silvia Ottaviani Giacomo Casalini Peter J Richardson Vanessa Monteil Volker M Lauschke Ali Mirazimi ..., EMBO Molecular Medicine

Drug May Offer New Approach Against Rheumatoid ArthritisMay 18th, 2023
Lilly's Peresolimab Phase 2a Rheumatoid Arthritis Trial Published in the New England Journal of MedicineMay 18th, 2023
Artax Biopharma Expands Company's Scientific Advisory BoardNovember 15th, 2022
Join now to see all